|Mr. Thomas J. Shaw||Founder, Chairman, Pres & CEO||516.72k||N/A||1951|
|Mr. John W. Fort III||Director, VP, CFO, Principal Accounting Officer & Treasurer||204k||N/A||1969|
|Ms. Michele M. Larios||VP, Gen. Counsel & Sec.||351.01k||223k||1966|
|Mr. Russell B. Kuhlman||VP of Sales Devel.||156.71k||91.57k||1954|
|Ms. Kathryn M. Duesman||Exec. Director of Global Health||284.52k||208.86k||1963|
|Mr. Lawrence G. Salerno||Director of Operations||N/A||N/A||1960|
|Ms. Patti S. King||Director of National Accounts||N/A||N/A||1958|
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holder; allergy tray; IV safety catheter; Patient Safe syringes and Luer Caps; VanishPoint blood collection set; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Retractable Technologies, Inc.’s ISS Governance QualityScore as of September 26, 2021 is 8. The pillar scores are Audit: 8; Board: 10; Shareholder Rights: 8; Compensation: 4.